Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Non-inferiority Trial of MVA-BN vs ACAM2000 for Smallpox
NCT01913353Phase 3Completed
- Sponsor
- Bavarian Nordic
- Start
- Mar 2015
- Primary completion
- Mar 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started Mar 2015; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT01913353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913353.